Endocrinol Metab.  2025 Feb;40(1):64-66. 10.3803/EnM.2024.2263.

Redefining Polycystic Ovary Syndrome: Transformative Diagnostic and Management Changes in the 2023 Guidelines

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea


Figure

  • Fig. 1. Updated diagnostic algorithm based on the 2023 guideline for polycystic ovary syndrome (PCOS). aAt all stages of diagnosing PCOS, other potential causes (e.g., Cushing’s syndrome, adrenal tumors) should be excluded using biochemical parameters such as thyroidstimulating hormone, prolactin, 17-hydroxyprogesterone, follicle-stimulating hormone, or luteinizing hormone. For adolescents, PCOS can be diagnosed based on the presence of both hyperandrogenism and ovulatory dysfunction, without requiring ultrasound or anti-Müllerian hormone testing.


Reference

1. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:41.
Article
2. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2:16057.
Article
3. Kim JH, Jung MH, Hong SH, Moon N, Kang DR. Age-adjusted prevalence and characteristics of women with polycystic ovarian syndrome in Korea: a nationwide population-based study (2010-2019). Yonsei Med J. 2022; 63:794–8.
Article
4. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33:1602–18.
Article
5. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189:G43–64.
6. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013; 28:777–84.
Article
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr